共 75 条
- [1] Ahluwalia M(2016)Metastatic brain tumors Am Brain Tumor Assoc 6 114-7
- [2] Vogelbaum M(2014)Brain metastasis and treatment F1000Prime Rep 4 1-129
- [3] Chao S(2015)Prognostic scores for brain metastasis patients: use in clinical practice and trial design Chinese Clin Oncol 34 123-2819
- [4] Mehta M(2016)Extended survival and prognostic factors for patients with ALK-rearranged non–small-cell lung cancer and brain metastasis J Clin Oncol 34 2814-135
- [5] Venur AV(2016)Management of brain Metastases in ALK-positive non-small-cell lung cancer J Clin Oncol 373 123-1833
- [6] Ahluwalia MS(2015)Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer N Engl J Med 375 1823-1639
- [7] Johung KL(2016)Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer N Engl J Med 373 1627-70
- [8] Yeh N(2015)Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer N Engl J Med 71 64-1266
- [9] Desai NB(2008)Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis Int J Radiat Oncol Biol Phys 25 1260-86
- [10] Rusthoven CG(2007)Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function J Clin Oncol 109 77-751